Clinical Trials Directory

Trials / Completed

CompletedNCT00443677

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
307 (actual)
Sponsor
Gruppo Italiano Studio Linfomi · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the toxicities of the COPPEBVCAD vs BEACOPP vs ABVD regimens.

Conditions

Interventions

TypeNameDescription
DRUGCOPPEBVCAD vs BEACOPP vs ABVD

Timeline

Start date
2000-04-01
Completion
2007-06-01
First posted
2007-03-06
Last updated
2009-03-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00443677. Inclusion in this directory is not an endorsement.

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (NCT00443677) · Clinical Trials Directory